DJ Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ slipped 3.43% to $7.89 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.13% to 38,612.24 and the NASDAQ Composite Index falling 0.32% to 15,580.87.
The stock's fall snapped a four-day winning streak.
Inovio Pharmaceuticals Inc. closed $9.45 short of its 52-week high ($17.34), which the company reached on February 22nd.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ rose 0.52% to $158.68, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 0.29% to $27.67.
Trading volume (288,806) remained 150,772 below its 50-day average volume of 439,578.
Data source: Dow Jones Market Data, FactSet. Data compiled February 21, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 21, 2024 17:31 ET (22:31 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments